Dr. Kodali Murali Krishna, MD
Cellular Therapy and Transplantation (Stanford University), American Board of Hematology (Washington University, St. Louis), American Board of Medical Oncology (University of Missouri)
Physician and Faculty at MD Anderson Cancer Center, Arizona
Faculty at University of Arizona
As a Chairman and CEO, Dr. Murali Krishna Kodali would be responsible for the overall implementation of the project. His previous experience in building cellular therapy projects would be a great asset in implementing this project. He is also an inspector for FACT (Foundation for the Accreditation of Cellular Therapy) which oversees the quality requirements of Cellular Therapy programs across the globe. His all-round experience, knowledge of the laboratory processes, and guidelines for cellular therapy would be instrumental in establishing this company.
Dr. Kodali Lavanya, MD
Solid Organ Transplantation (University of Tennessee), American Board of Nephrology (University of Florida)
Director of Pancreas Transplant Program, Mayo Clinic, Arizona
Physician and Faculty at the Mayo Clinic, Arizona
Dr. K Rama Krishna, MD, DC
Physician and Cardiologist
Professor Emeritus NTR University of Health Sciences
Professor of Medicine and Division Chief Blood and Marrow Transplantation and Cellular Therapy
Stanford University
Director of Translational Research, Center for Childhood Cancer Research
Medical Director of the Cell and Gene Therapy Laboratory
Children's Hospital of Philadelphia, PA, USA
helixcell.org
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.